Cancer risk is a scary topic for patients to discuss with a dental practitioner. Using non-invasive equipment is more appealing for patients, improving compliance and reducing fears.
The BeVigilant™ OraFusion™ System from Vigilant Biosciences® can reliably identify the biomarkers in the mouth associated with oral cancer, doing so in 15 minutes or less. It uses a simple saliva test that is an agreeable alternative to more invasive procedures, promoting convenience and ease for patients.
With a short waiting time for results that determine a low, moderate or high risk, practitioners can help organise any treatment decisions that may have to be made. This can prevent an agonising wait for patients and will empower the practitioner that they are doing all they can, as quickly as they can.
By using simple and comfortable solutions for identifying oral cancer risk, practitioners can reduce the anxieties and fears that patients may have towards cancer, allowing both to tackle the problem together. Try the BeVigilant™ OraFusion™ System today.
For more information, visit www.vigilantbiosciences.com or email info@vigilantbiosciences.com
